BRIEF-Clarus Therapeutics - Co, Havah Therapeutics Announced Licensing Agreement

Reuters

May 25, 2021

May 25 (Reuters) - Blue Water Acquisition Corp :

* CLARUS THERAPEUTICS - CO, HAVAH THERAPEUTICS ANNOUNCED LICENSING AGREEMENT

* CLARUS THERAPEUTICS - UNDER AGREEMENT CO TO ACQUIRE EXCLUSIVE WORLDWIDE (EXCLUDING AUSTRALIA) DEVELOPMENT & COMMERCIALIZATION RIGHTS FOR HAVAH T+AI

* CLARUS THERAPEUTICS - CO WILL BE RESPONSIBLE FOR FUTURE GLOBAL DEVELOPMENT AND REGULATORY ACTIVITIES FOR CLAR-121, EXCLUDING AUSTRALIA

* CLARUS THERAPEUTICS - TO PAY HAVAH UPFRONT PAYMENT OF $500,000 UPON SIGNING, HAVAH MAY BE ELIGIBLE FOR UP TO $10.75 MILLION IN POTENTIAL MILESTONE PAYMENTS

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2138167537"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2138167537\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2138167537?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-05-25 20:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2138167537","market":"us","top_or_hot":-1,"title":"BRIEF-Clarus Therapeutics - Co, Havah Therapeutics Announced Licensing Agreement","media":"Reuters","content":"<html><body><p>May 25 (Reuters) - Blue Water Acquisition Corp   :</p><p>   * CLARUS THERAPEUTICS - CO, HAVAH THERAPEUTICS ANNOUNCED LICENSING AGREEMENT</p><p>   * CLARUS THERAPEUTICS - UNDER AGREEMENT CO TO ACQUIRE EXCLUSIVE WORLDWIDE (EXCLUDING AUSTRALIA) DEVELOPMENT &amp; COMMERCIALIZATION RIGHTS FOR HAVAH T+AI</p><p>   * CLARUS THERAPEUTICS - CO WILL BE RESPONSIBLE FOR <a href=\"https://laohu8.com/S/FUTR.UK\">FUTURE</a> GLOBAL DEVELOPMENT AND REGULATORY ACTIVITIES FOR CLAR-121, EXCLUDING AUSTRALIA</p><p>   * CLARUS THERAPEUTICS - TO PAY HAVAH UPFRONT PAYMENT OF $500,000 UPON SIGNING, HAVAH MAY BE ELIGIBLE FOR UP TO $10.75 MILLION IN POTENTIAL MILESTONE PAYMENTS</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Clarus Therapeutics - Co, Havah Therapeutics Announced Licensing Agreement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Clarus Therapeutics - Co, Havah Therapeutics Announced Licensing Agreement\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-05-25 20:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>May 25 (Reuters) - Blue Water Acquisition Corp   :</p><p>   * CLARUS THERAPEUTICS - CO, HAVAH THERAPEUTICS ANNOUNCED LICENSING AGREEMENT</p><p>   * CLARUS THERAPEUTICS - UNDER AGREEMENT CO TO ACQUIRE EXCLUSIVE WORLDWIDE (EXCLUDING AUSTRALIA) DEVELOPMENT &amp; COMMERCIALIZATION RIGHTS FOR HAVAH T+AI</p><p>   * CLARUS THERAPEUTICS - CO WILL BE RESPONSIBLE FOR <a href=\"https://laohu8.com/S/FUTR.UK\">FUTURE</a> GLOBAL DEVELOPMENT AND REGULATORY ACTIVITIES FOR CLAR-121, EXCLUDING AUSTRALIA</p><p>   * CLARUS THERAPEUTICS - TO PAY HAVAH UPFRONT PAYMENT OF $500,000 UPON SIGNING, HAVAH MAY BE ELIGIBLE FOR UP TO $10.75 MILLION IN POTENTIAL MILESTONE PAYMENTS</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BLUW","symbol_name":"Blue Water Acquisition Corp.","start_time":0,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2138167537","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2138167537","pubTimestamp":1621945112,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"May 25 (Reuters) - Blue Water Acquisition Corp   :   * CLARUS THERAPEUTICS - CO, HAVAH THERAPEUTICS ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BLUW":"Blue Water Acquisition Corp."},"translate_title":"Brief-Clarus Therapeutics-Co,Havah Therapeutics宣布许可协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BLUW":0.9},"content_text":"May 25 (Reuters) - Blue Water Acquisition Corp   :   * CLARUS THERAPEUTICS - CO, HAVAH THERAPEUTICS ANNOUNCED LICENSING AGREEMENT   * CLARUS THERAPEUTICS - UNDER AGREEMENT CO TO ACQUIRE EXCLUSIVE WORLDWIDE (EXCLUDING AUSTRALIA) DEVELOPMENT & COMMERCIALIZATION RIGHTS FOR HAVAH T+AI   * CLARUS THERAPEUTICS - CO WILL BE RESPONSIBLE FOR FUTURE GLOBAL DEVELOPMENT AND REGULATORY ACTIVITIES FOR CLAR-121, EXCLUDING AUSTRALIA   * CLARUS THERAPEUTICS - TO PAY HAVAH UPFRONT PAYMENT OF $500,000 UPON SIGNING, HAVAH MAY BE ELIGIBLE FOR UP TO $10.75 MILLION IN POTENTIAL MILESTONE PAYMENTSSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}